Company Filing History:
Years Active: 2008
Title: Kenji Hattori: Pioneering Innovations in Vascular Biology
Introduction: Kenji Hattori is a notable inventor based in Kaisei-machi, Japan, recognized for his contributions to the field of vascular biology. With a focus on immortalized cell lines, Hattori's work has significant implications for medical research and therapeutic applications.
Latest Patents: Hattori holds a patent for an "Immortalized Vascular Adventitial Cell Line." This groundbreaking invention aims to provide an immortalized capillary pericyte line that retains the original properties of the cellular tissue. The patented method includes the establishment of a cell line from the cerebral tissue of a transgenic rat, which carries the SV40 thermo-sensitive large T antigen gene. This innovative work results in a cell line capable of expressing specific receptors and exhibiting the ability to deposit calcium on a matrix under dense culture conditions.
Career Highlights: As a member of the Japan Science and Technology Agency, Kenji Hattori has significantly advanced the research on vascular cells. His innovative approach to developing immortalized cell lines not only enhances our understanding of vascular biology but also facilitates screening methods for various useful substances, showcasing his vital role in the scientific community.
Collaborations: Hattori collaborates with esteemed colleagues, including Hisashi Iizasa and Emi Nakashima. This partnership reflects a strong commitment to advancing research in this specialized field, combining their expertise to push the boundaries of knowledge in vascular biology.
Conclusion: Kenji Hattori's contributions through his patented innovations provide valuable insights and tools for researchers in the medical field. His work exemplifies the importance of scientific innovation and collaboration, paving the way for future breakthroughs in vascular research and therapy.